Techniclone (TCLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EZLibra who wrote (2410)	8/13/1998 9:12:00 PM
From: Tim K	Read Replies (1) of 3702

The posts on the CLTR thread about TCLN illustrate why TCLN doesn't have a higher share price (yet). All one needs to do is go to the Yahoo quote/profile pages and you'll see: Cash: $.09 per share - $3.77 million total. Further due diligence reveals $3million/qrtr burn rate, $72million in debt. Compare this to the other biotechs out there like ENMD and CLTR and at first glance, at least based on the financials, it isn't a prudent investment. This isn't brain surgery (excuse the pun). It will take better financials, or a blockbuster treatment success announcement to get the average investor to take the risk. Those of us who have researched the technology and its potential and see the positive things current management is doing, the advances in the clinicals, and financial improvements are willing to take the risk. I think we will be well rewarded. Davis - you represent us well. To bad golfdad doesn't want to be quoted - even the competition respects him. Tim K

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next